I think we need to argue that the report is no longer valid due to material developments at both Brockman (Opthalmia, rail etc) and the broader market place.
The report (for what it is worth) cannot be held up as infinitely relevant and accurate after so many significant changes.
If the potential (win/win) laywers are looking for a great circuit breaker that demonstrates the variation in current value vs what was put up last year, then they should commission their own report.
BRM Price at posting:
$2.39 Sentiment: None Disclosure: Held
